Animal Growth Promoters and Performance Enhancers Market by Product Antibiotic and Non-antibiotic (Hormones, Acidifiers, Feed Enzymes, Probioitcs & Prebiotics, Phytogenics), Animal (Poultry, Porcine, Livestock, Aquaculture) – Global Forecast to 2024

2020-01-22
Price :
Published : Jan-2020
No. of Pages : 160

The animal growth promoters and performance enhancers market projected to grow at a CAGR of 5.9% during the forecast period (2019–2024).”

The global animal growth promoters and performance enhancers market is projected to reach USD 18.5 billion by 2024 from an estimated USD 13.9 billion in 2019, at a CAGR of 5.9%during the forecast period. The key factors driving the growth of this market is the increasing global meat demand, research into alternatives to antibiotics, and the need to deal with epidemics and environmental factors. However, various countries have stringent regulations in place against antibiotics and particular growth promoters, which has affected their adoption.

“By type, the non-antibiotic growth promoters segment is expected to grow at the highest CAGR during the forecast period (2019–2024).”

On the basis of type, the market is segmented into antibiotic and non-antibiotic growth promoters. The non-antibiotic growth promoters segment commanded the largest share of the animal growth promoters and performance enhancers market in 2018.This large share of this segment is due to the economic benefits, a wide range of substances (acidifiers, prebiotics & probiotics, feed enzymes, phytogenic, hormones and others growth promoters), numerous applications in various production animals, greater sustainability, and the increasing number of regulations on antibiotics.

“By animal type, the poultry segment is expected to dominate the market during the forecast period (2019–2024).”

Based on animal type, the market is segmented into poultry, porcine, livestock, aquaculture, and other animals (equine, rabbit, camel, deer, yak, and geese).The poultry segment marked the largest share of the animal growth promoters and performance enhancers market in 2018. The large market share of this segment can be attributed to the increasing demand for poultry meat & eggs, novel diet approaches, and antibiotics phase-outs, resulting in the development of alternatives.

“The Europe region to witness the highest growth during the forecast period (2019–2024).”

The Europe market is projected to register the highest growth during the forecast period. Factors such as rising in domestic livestock, poultry and pork production, and decreasing meat imports owing to the ban of certain growth promoters in Europe are driving the growth for the animal growth promoters and performance enhancers market in Europe. Other factors also include technological advancements in animal production in this region and increasing meat production.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1–21%, Tier 2–26%, and Tier 3–53%
  • By Designation: C-level–32%, Director-level–23%, and Others–45%
  • By Region: North America–36%, Europe–32%, Asia Pacific–17%, RoW–15%

Prominentplayers in the global animal growth promoters and performance enhancers market includeare Merck and Co. Inc. (US), Cargill Inc. (US), Royal DSM N. V. (Germany), Bupo Animal Health (SA), Elanco Animal Health Inc. (US), CHR Hansen (UK), Alltech Inc. (US),Phibro Animal Health Corporation (US), Kemin Industries (US), and SHV (Nutreco) (UK).

Research Coverage:

The report analyzes the animal growth promoters and performance enhancers market and aims at estimating the market size and future growth potential of this market based on various segments such as product, animal type, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one, or any combination of the below mentioned five strategies.

This report provides insights into the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the animal growth promoters and performance enhancers market. The report analyzes the market based on the product, animal type, and region.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the animal growth promoters and performance enhancers market.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various animal growth promoters and performance enhancers equipment across regions.
  • Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the animal growth promoters and performance enhancers market.
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the animal growth promoters and performance enhancers market.
Filed in: Biotechnology
Publisher : marketsandmarkets
More Reports
Title Price Buy Now

Synthetic Biology Market by Tools (Oligonucleotides, Enzymes, Synthetic Cells), by Technology (Gene Synthesis, Bioinformatics), by Application (Tissue Regeneration, Biofuel, Renewable Energy, Food & Agriculture, Bioremediation) – Global Forecast to 2025

“The synthetic biology market is projected to grow at a CAGR of 23.9% during the forecast period (2020–2025).” The synthetic biology market is projected to reach USD 19.8 billion by 2025 from USD 6.8 billion in 2020, at a CAGR of 23.9%.Factors such as the increasing demand for synthetic genes and synthetic cells, wide range of applications of synthetic biology, declining cost of DNA sequencing and synthesizing, increasing R&D funding and initiatives in synthetic biology, and increasing investments in the market are propelling the growth of this market. However, rising biosafety, biosecurity, and ethical concerns related to synthetic biology is likely to hamper the growth of this market. “The oligonucleotides and synthetic DNA segment is expected to grow at the highest rat......
$5650

Drug Discovery Services Market by Process (Target Selection, Validation, Lead Optimization), Type (Medicinal Chemistry, DMPK), Drug Type (Biologics, Small Molecules), Therapeutic (Oncology, Neurology), Company (Tier 1, 2, 3) – Global Forecast to 2025

“Drug discovery services market to register a CAGR of 12.1% from 2020 to 2025.” The global drug discovery services market is projected to reach USD 19.1 billion by 2025 from USD 10.7 billion in 2020, at a CAGR of 12.1% from 2020 to 2025. The growth of the industry is driven primarily by factors such as growing R&D expenditure in the pharmaceutical & biopharmaceutical industry, increasing demand for outsourcing analytical testing and clinical trial services, initiatives for research on rare diseases and orphan drugs, and focus on drug discovery. Growth in the biologics market and patent expiries will further provide opportunities in the drug discovery services industry. Developing economies are expected to offer a wide range of growth opportunities for players in the market. ......
$5650

Vaccines Market by Technology (Live, Toxoid, Recombinant), Disease (Pneumococcal, Influenza, DTP, Rotavirus, TT, Polio, MMR, Varicella, Dengue, TB, shingles, Rabies), Route (IM, SC, ID, Oral), Patient (Pediatric, Adult), Type – Global Forecast to 2024

“The vaccines market is projected to grow at a CAGR of 7.0% during the forecast period (2019–2024).” The global vaccines market is projected to reach USD 58.4 billion by 2024 from USD 41.7 billion in 2019, at a CAGR of 7.0%during the forecast period. The key factors driving the growth of this market include the high prevalence of infectious diseases, growing support for vaccine R&D, investments in vaccine development, and rising focus on immunization. However, the huge capital investments required for developing vaccines may restrain market growth. “The pneumococcal disease segment will continue to dominate the vaccines market during the forecast period.” On the basis of disease indication, the vaccines market is segmented into pneumococcal disease, influenza, DTP, h......
$5650

Gene Therapy Market by Vectors [Non-viral (Oligonucleotides), Viral (Retroviral (Gammaretroviral, Lentiviral)), Adeno-associated], Indication (Cancer, Neurological Diseases), Delivery Method (In Vivo, Ex Vivo), Region – Global Forecast to 2024

“High incidence of cancer& other target diseases is a major factor driving the growth of the gene therapy market” The global gene therapy market is projected to reach USD 13.0 billion by 2024 from USD 3.8 billion in 2019, at a CAGR of 27.8% during the forecast period. The high incidence of cancer and other target diseases, availability of reimbursement, and the launch of new products are the major factors driving the growth of this market. In addition, the strong product pipeline of market players is expected to offer significant growth opportunities in the coming years. However, the high cost of treatment is expected to hamper market growth to a certain extent in the coming years. “Neurological diseases segment accounted for the largest share of the gene therapy market, by......
$5650

Flow Cytometry Market by Technology (Cell-based, Bead-based), Product (Analyzer, Sorter, Reagents, Consumables, Software), End user (Academia, Research Labs, Hospitals, Clinical Laboratories, Pharma-Biotech Cos), Application – Global Forecasts to 2025

“The global flow cytometry market is projected to grow at a CAGR of 8.3%.” The global flow cytometry market size is projected to reach USD 6.4 billion by 2025 from USD 4.0 billion in 2019, growing at a CAGR of 8.3% from 2019 to 2025. The key factors driving the growth of this market include technological advancements in flow cytometers, the increasing adoption of flow cytometry in research and clinical trials, growing focus on immunology and immuno-oncology research, increasing incorporation of AI platforms in flow cytometry workflows and advancements in flow cytometry software, high incidence and prevalence of target diseases, and the availability of novel products. “The bead-based technology segment is expected to grow at the fastest rate during the forecast period.” By ......
$5650

Isothermal Nucleic Acid Amplification Technology/INAAT Market by Product (Assay & Kit, System), Application (Infectious disease [HIV, Influenza], Blood Screening), Type (LAMP, SDA, NASBA, HDA), End User, Region – Global Forecast to 2024

“The rising prevalence of infectious diseases and the introduction of newer pathogens, and the cost-benefits of INAAT is expected to drive the overall growth of the INAAT market” The global isothermal nucleic acid amplification technology (INAAT) market size is expected to grow from USD 1.9 billion in 2019to USD 3.3 billion by 2024, at a CAGR of 11.0% during the forecast period. The major factors driving the growth of this market include the rising prevalence of infectious diseases and the introduction of newer pathogens, the need for prompt diagnosis, the increasing number of blood transfusions and donations, and the cost-benefits of INAAT. However, the extensive usage and reliance on PCR are expected to limit the adoption of INAAT. “Assay, kits and reagents segment is expecte......
$4950

Laboratory Filtration Market by Product (Filtration Assembly, Filter Media Accessories), Technology (Ultrafiltration, Microfiltration, Nanofiltration, RO), End User (Pharmaceutical, Biopharmaceutical Company, F&B), Region – Global Forecast to 2025

“Rising demand for lab filters from pharmaceutical & biotechnology companies to drive market growth” The global laboratory filtration market is projected to reach USD 4.1 billion by 2025 from USD 2.5 billion in 2019, at a CAGR of 8.3%. Growth in this market is majorly driven by the growing demand for membrane filtration technology, increasing manufacturing of biosimilars, and the growing focus on developing large-molecule biopharmaceuticals. “The filtration media segment will register the highest growth in the market, by product” Based on product, the market is segmented into filtration media (filter papers, membrane filters, syringe and syringeless filters, filtration microplates, and other filtration media), filtration assemblies (microfiltration assemblies, reverse ......
$5650

Tangential Flow Filtration Market by Product (TFF System, Membrane Filter), Application (Bioprocess, Viral Vector Purification), Technique (Ultrafiltration, Microfiltration), Material Type (PES/PS Membrane), Region – Global Forecast to 2024

“Advantages of tangential flow filtration over normal flow filtration (NFF) are expected to drive the overall growth of the tangential flow filtration market.” The tangential flow filtration market is expected to grow from USD 944 million in 2019 to USD 1,590 million by 2024, at a CAGR of 11.0% during the forecast period. The major factors driving the growth of this market include the advantages of tangential flow filtration (TFF) over normal flow filtration (NFF), increasing adoption of single-use technologies, and increased cGMP adoption. However, the high capital expenditure required to set up new production facilities is a major factor restraining the growth of this market. “The membrane filter segment is expected to grow at the highest CAGR during the forecast period.” ......
$5650

Biotechnology – Thematic Research

Biotechnology - Thematic Research Summary At its core, biotechnology is harnessing biological and molecular systems to develop products and processes. This report focuses on the most important and fastest growing areas of biotechnology which are its application to health and medicine. It is divided into three areas: agricultural biotechnology, which includes development of genetically modified crops; industrial biotechnology, which includes production of chemicals, paper and textiles; and medical biotechnology which includes the themes covered in this report such as biosimilars and the microbiome. The thematic report also predicts that companies which make the most effective use of the modern data tools are going to be successful while, in the long run, big pharma could be threatened b......
$1950

Amyotrophic Lateral Sclerosis: Opportunity Analysis and Forecast to 2027

Amyotrophic Lateral Sclerosis: Opportunity Analysis and Forecast to 2027 Summary Amyotrophic Lateral Sclerosis (ALS) is a motor neuron degenerative disease which affects both upper motor neurons (UMN) and lower motor neurons (LMN). It is a progressive disease, with patients becoming increasingly dependent on carers and physicians as time from onset increases, and ultimately, it is fatal. ALS can be split into two origins, hereditary - which is known as FALS (Familial ALS) or idiopathic - known as SALS (sporadic ALS). Currently there are only two drugs on the market that are approved for the treatment of ALS; Sanofi's Rilutek (riluzole) and Mitsubishi Tanabe Pharma's Radicava (edaravone). The drugs were special cases in terms of FDA approval, they did not meet the normal regulatory requi......
$10995
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy